Global Orodispersible Film Market Research Report 2022

Orodispersible film (ODF) is a new oral pharmaceutical form, whose characteristics are able to improve the treatment compliance of certain groups of subjects whose needs are not met by capsules and tablets. They take the form of small, thin, flexible sheets, similar to postage stamps that, when placed inside the mouth, dissolve rapidly in contact with saliva. The dissolution time is usually a few dozen seconds and in any case no more than one minute. The weight of a single film is usually a few hundred mg, meaning that very little saliva is required for dissolution.

Due to the COVID-19 pandemic, the global Orodispersible Film market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Orodispersible Film market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Orodispersible Film landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Natural Polymer accounting for % of the Orodispersible Film global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital and Clinic segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Orodispersible Film include Aquestive Therapeutics, Kyukyu Pharmaceutical, Tapemark, Shilpa Therapeutics, BioDelivery(BDSI), IntelGenx, CL Pharm, Lubrizol Life Science and Adhex Pharma, etc. In terms of revenue, the global 3 largest players have a % market share of Orodispersible Film in 2021.
This report focuses on Orodispersible Film volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Orodispersible Film market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Orodispersible Film Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Natural Polymer
Synthetic Polymer
Segment by Application
Hospital and Clinic
Drug Store
E-commerce
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Aquestive Therapeutics
Kyukyu Pharmaceutical
Tapemark
Shilpa Therapeutics
BioDelivery(BDSI)
IntelGenx
CL Pharm
Lubrizol Life Science
Adhex Pharma
DK Livkon
Arx Pharma
Aavishkar
ZIM Laboratories
Umang Pharmaceuticals
Cure Pharmaceutical